Search

Your search keyword '"Waterhouse, David"' showing total 10 results
Start Over Author "Waterhouse, David" Journal jco oncology practice
10 results on '"Waterhouse, David"'

2. Changes Over Time in COVID-19 Severity and Mortality in Patients Undergoing Cancer Treatment in the United States: Initial Report From the ASCO Registry

Author

Mileham, Kathryn F., Bruinooge, Suanna S., Aggarwal, Charu, Patrick, Alicia L., Davis, Christiana, Mesenhowski, Daniel J., Spira, Alexander, Clayton, Eric J., Waterhouse, David, Moore, Susan, Jazieh, Abdul-Rahman, Chen, Ronald C., Kaltenbaugh, Melinda, Williams, Jen Hanley, Gralow, Julie R., Schilsky, Richard L., and Garrett-Mayer, Elizabeth

Published
2021
Full Text
View/download PDF

5. Defining the Educational Needs for a Community-Based Hematology/Oncology Career: A National Needs Assessment

Author

Agrawal, Shubham, Patell, Rushad, Dodge, Laura E., Pegher, Jennifer W., Coleman, Robert L., Waterhouse, David Michael, Roberts, Daniel Aaron, and Rangachari, Deepa

Abstract

In the U.S.: (1) most cancer care is in the community, (2) most H/O fellowships are in academic settings. Goal-concordant fellowship training = evidence-based education.

Published
2024
Full Text
View/download PDF

6. Integration of Genetic Testing and Counseling in Patients With Breast Cancer in a Large, Multisite Community-Based Practice.

Author

Mendenhall, Molly A., Guinigundo, Andrew, Davies, Dan, Ward, Patrick, Drosick, David R., and Waterhouse, David M.

Subjects
CANCER patient psychology, GENETIC testing, MEDICAL protocols, DESCRIPTIVE statistics, RESEARCH funding, GENETIC counseling, BREAST tumors
Abstract

PURPOSE Despite data-driven consensus recommendations, there remains significant nonadherence to genetic screening and testing. More than 300,000 patients are diagnosed with breast cancer annually, with one third of these estimated to be eligible for homologous recombination deficiency (HRD)/BRCA testing following National Comprehensive Cancer Network (NCCN) guidelines. Only 35% of eligible patients are referred for genetic counseling. METHODS The goal of this project was to apply NCCN guidelines for germline genetic testing to all new patients with breast cancer within a large community oncology practice to improve HRD/BRCA testing. Plan-Do-Study-Act methodology was used, and cycles were built on a proven teaching infrastructure. In cycle 1, providers were educated and directed to use electronic health record (EHR) templates in the setting of an initial diagnosis visit and treatment planning. Discreet data fields were created in the EHR during cycle 2 to streamline and automate the process. Appropriate patients were referred to the genetics team for further evaluation, counseling, and testing. Adherence to the plan was maintained and measured using data analytic reports and chart audits. RESULTS Of the 1,203 patients with breast cancer eligible for inclusion, 1,200 (99%) were screened according to NCCN guidelines. Of the screened patients, 631 (52.5%) met the referral/testing criteria. In total, 585 (92.7%) of the 631 were referred to a genetic specialist. Seven percent had previous referrals. A total of 449 (71%) patients were acceptable to genetics referral while 136 (21.5%) patients refused. CONCLUSION The implementedmethods of education, NCCN guidelines imbedded within provider notes, and discreet data fields in the EHR have proven to be highly effective in screening appropriate patients and ordering subsequent genetic referrals. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

8. Changes Over Time in COVID-19 Severity and Mortality in Patients Undergoing Cancer Treatment in the United States: Initial Report From the ASCO Registry

Author

Mileham, Kathryn F., primary, Bruinooge, Suanna S., additional, Aggarwal, Charu, additional, Patrick, Alicia L., additional, Davis, Christiana, additional, Mesenhowski, Daniel J., additional, Spira, Alexander, additional, Clayton, Eric J., additional, Waterhouse, David, additional, Moore, Susan, additional, Jazieh, Abdul-Rahman, additional, Chen, Ronald C., additional, Kaltenbaugh, Melinda, additional, Williams, Jen Hanley, additional, Gralow, Julie R., additional, Schilsky, Richard L., additional, and Garrett-Mayer, Elizabeth, additional

Published
2022
Full Text
View/download PDF

9. Recommendations to Streamline and Standardize Clinical Trial Site Feasibility Assessments: An ASCO Research Statement

Author

Kurbegov, Dax, primary, Hurley, Patricia, additional, Waterhouse, David M., additional, Robert, Nicholas J., additional, Nowakowski, Grzegorz S., additional, Thompson, Michael A., additional, Bruinooge, Suanna S., additional, Schilsky, Richard L., additional, Byatt, Leslie, additional, Dempsey, Kandie, additional, Dawson, Casey, additional, Hofacker, Janie, additional, Liu, Jane, additional, MacDougall, A. Kate, additional, and Kim, Edward S., additional

Published
2021
Full Text
View/download PDF

10. Early Impact of COVID-19 on the Conduct of Oncology Clinical Trials and Long-Term Opportunities for Transformation: Findings From an American Society of Clinical Oncology Survey

Author

Waterhouse, David M., primary, Harvey, R. Donald, additional, Hurley, Patricia, additional, Levit, Laura A., additional, Kim, Edward S., additional, Klepin, Heidi D., additional, Mileham, Kathryn Finch, additional, Nowakowski, Grzegorz, additional, Schenkel, Caroline, additional, Davis, Courtney, additional, Bruinooge, Suanna S., additional, and Schilsky, Richard L., additional

Published
2020
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results